Recombinant CTLA-4 (Ipilimumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CTLA-4 (Ipilimumab Biosimilar) products
- CTLA-4 (Ipilimumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CTLA-4 (Ipilimumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Ipilimumab Biosimilar - Anti-CTLA-4 mAb
- Characteristics
- Antibody Type: IgG1Kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CTLA-4 (Ipilimumab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer pH 7.5
- Storage
- 4 °C,-20 °C
- Storage Comment
- 4°C for short term, -20°C for long term
-
- Target
- CTLA-4 (Ipilimumab Biosimilar)
- Abstract
- CTLA-4 (Ipilimumab Biosimilar) Products
- Synonyms
- CD antibody, CD152 antibody, CELIAC3 antibody, CTLA-4 antibody, GRD4 antibody, GSE antibody, IDDM12 antibody, cytotoxic T-lymphocyte associated protein 4 antibody, CTLA4 antibody
- Target Type
- Biosimilar
- Background
- Ipilimumab
-
You are here:
